About US
Contact us
Position：Home > Phexcom News >
-
Acquisition of Pharmaceutical Sugar Spheres Product Line from Paulaur Corporation19thJanuary 2016 Subject: Acquisition of Pharmaceutical Sugar Spheres Product Line from Paulaur Corporation Dear Customer: We are pleased to announce that effective 18thJanuary 2016, Colorcon, Inc.2016/1/27
-
Spurned Shire preps new takeover offer for longtime target BaxaltaLast month, Shire ($SHPG) said it still believed an acquisition for Baxalta ($BXLT)--a target that rejected it almost four months back--would make a "highly strategic combination." And now, it's prepa2015/11/26
-
Turing offers discounts instead of cutting controversial list price on DaraprimTuring Pharmaceuticalshas been saying for a while now that it would lower the price of its toxoplasmosis med, Daraprim, responding to growing backlash from lawmakers and the public after it bought the2015/11/26
-
Amgen nabs Kyprolis OK in Europe as U.S. competition mountsIt's been more than three years since Amgen's ($AMGN) multiple myeloma treatment Kyprolis won approval from U.S. regulators. Now, it's finally done the same in Europe--and with competition heating up2015/11/26
-
Novartis' Entresto gets the go-ahead in EuropeNovartis' ($NVS) blockbuster-in-waiting,Entresto, has been handed its second big approval. The new heart failure drug has snagged an OK from theEuropean Commission. The Swiss drugmaker said today tha2015/11/25
-
Trump, Clinton lash out at Pfizer over Allergan deal agreementPfizer ($PFE) may be amped about its brand-new agreement to tie up with Allergan ($AGN) and move to tax-advantaged Ireland. But U.S. politicians? They're not so thrilled with the idea. Presidential c2015/11/25
-
Ever-loyal Ackman raises stake in embattled ValeantMany Valeant ($VRX) investors have fled in recent weeks as the company was hit with drug pricing controversy, subpoenas and allegations that it used its relationship with specialty pharmacy Philidor t2015/11/25
-
Cancer, hep C and other specialty meds to drive global drug market to $1.4T by 2020Global drug spending will take a major leap over the next 5 years, according to a new report from the IMS Institute of Healthcare Informatics. Worldwide spending on pharma products is expected to shoo2015/11/19
-
Allergan demands CEO slot for Saunders as condition for Pfizer buyout: ForbesIf Pfizer ($PFE) does make a friendly deal for Allergan ($AGN), CEOIan Readwill be giving up his seat at the helm. That's the word from sources at Pfizer, who toldForbes' John LaMattina that current n2015/11/19
-
Shortages, soaring generic injectable drug prices leave hospitals scramblingHospital pharmacy folk understand supply and demand and realize that when there is a shortage of the generic injectables drugs they routinely use, a big price hike is coming. What they don't get is wh2015/11/19